Insider Shareholders with Direct Ownership of Century Therapeutics, Inc. (IPSC)
IPSC Quotes by TradingView
This section provides a comprehensive overview of the insiders with direct ownership of Century Therapeutics, Inc. (IPSC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Century Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
Aktiengesellschaft Bayer
> 10% Shareholder |
12,675,838 | 0 | 12,675,838 $6.84 Million | 1 |
Jun 22, 2021
Added 5.59%
|
Versant Venture Capital Vi, L.P.
> 10% Shareholder |
9,936,011 | 1,464,800 | 11,452,014 $6.18 Million | 4 |
Aug 09, 2022
Reduced 3.09%
|
Fujifilm Cellular Dynamics, Inc.
> 10% Shareholder |
3,974,404 | 0 | 6,955,207 $3.76 Million | 1 |
Jun 22, 2021
Added 36.36%
|
Brent Pfeiffenberger
President and CEO |
1,992,204 | 280,394 | 1,711,810 $924,377 | 6 |
Mar 11, 2025
Added 23.35%
|
Douglas Carr
SVP Finance & Operations |
262,478 | 36,842 | 411,181 $222,037 | 14 |
Mar 11, 2025
Added 18.87%
|
Gregory Russotti
Officer |
144,000 | 29,746 | 392,573 $211,989 | 11 |
Mar 11, 2025
Added 23.41%
|
Luis Borges
Chief Scientific Officer |
401,446 | 144,911 | 256,535 $138,528 | 8 |
Apr 03, 2023
Added 2.82%
|
Michael Craig Diem
Chief Financial Officer |
194,808 | 20,763 | 253,533 $136,907 | 3 |
Nov 01, 2023
Reduced 7.57%
|
Adrienne Farid
Chief Operations Officer |
241,750 | 64,251 | 251,717 $135,927 | 15 |
Mar 11, 2025
Added 32.28%
|
Chad Cowan
Chief Scientific Officer |
93,876 | 0 | 230,306 $124,365 | 2 |
Mar 11, 2025
Added 7.81%
|
Morgan Conn
Chief Finanical Officer |
79,648 | 0 | 79,648 $43,009 | 2 |
Mar 11, 2025
Added 19.67%
|
Hyam Levitsky
President of R&D |
24,000 | 0 | 24,000 $12,960 | 1 |
Mar 07, 2024
Added 50.0%
|
Daphne Quimi
Director |
5,000 | 0 | 5,000 $2,700 | 1 |
Sep 12, 2024
Added 50.0%
|
Showing 1 to 13 of 13 entries